2M5O

Solution NMR Structure CTD domain of NFU1 Iron-Sulfur Cluster Scaffold Homolog from Homo sapiens, Northeast Structural Genomics Consortium (NESG) Target HR2876C

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	1.0 mM [U-100% 13C; U-100% 15N] HR2876C.003, 5 mM DTT, 100 mM NaCl, 10 mM Tris-HCl pH 7.5, 0.02 % NaN3, 1.0 mM [U-10% 13C; U-100% 15N] HR2876C.006, 5 mM DTT, 100 mM NaCl, 10 mM Tris-HCl pH 7.5, 0.02 % NaN3, 1.0 mM [U-10% 13C; U-100% 15N] HR2876C.006, 5 mM DTT, 100 mM NaCl, 10 mM Tris-HCl pH 7.5, 0.02 % NaN3	90% H2O/10% D2O		6.5	ambient	298
2	2D 1H-13C HSQC	1.0 mM [U-100% 13C; U-100% 15N] HR2876C.003, 5 mM DTT, 100 mM NaCl, 10 mM Tris-HCl pH 7.5, 0.02 % NaN3, 1.0 mM [U-10% 13C; U-100% 15N] HR2876C.006, 5 mM DTT, 100 mM NaCl, 10 mM Tris-HCl pH 7.5, 0.02 % NaN3, 1.0 mM [U-10% 13C; U-100% 15N] HR2876C.006, 5 mM DTT, 100 mM NaCl, 10 mM Tris-HCl pH 7.5, 0.02 % NaN3	90% H2O/10% D2O		6.5	ambient	298
3	3D HNCO	1.0 mM [U-100% 13C; U-100% 15N] HR2876C.003, 5 mM DTT, 100 mM NaCl, 10 mM Tris-HCl pH 7.5, 0.02 % NaN3, 1.0 mM [U-10% 13C; U-100% 15N] HR2876C.006, 5 mM DTT, 100 mM NaCl, 10 mM Tris-HCl pH 7.5, 0.02 % NaN3, 1.0 mM [U-10% 13C; U-100% 15N] HR2876C.006, 5 mM DTT, 100 mM NaCl, 10 mM Tris-HCl pH 7.5, 0.02 % NaN3	90% H2O/10% D2O		6.5	ambient	298
4	3D CBCA(CO)NH	1.0 mM [U-100% 13C; U-100% 15N] HR2876C.003, 5 mM DTT, 100 mM NaCl, 10 mM Tris-HCl pH 7.5, 0.02 % NaN3, 1.0 mM [U-10% 13C; U-100% 15N] HR2876C.006, 5 mM DTT, 100 mM NaCl, 10 mM Tris-HCl pH 7.5, 0.02 % NaN3, 1.0 mM [U-10% 13C; U-100% 15N] HR2876C.006, 5 mM DTT, 100 mM NaCl, 10 mM Tris-HCl pH 7.5, 0.02 % NaN3	90% H2O/10% D2O		6.5	ambient	298
5	3D HNCACB	1.0 mM [U-100% 13C; U-100% 15N] HR2876C.003, 5 mM DTT, 100 mM NaCl, 10 mM Tris-HCl pH 7.5, 0.02 % NaN3, 1.0 mM [U-10% 13C; U-100% 15N] HR2876C.006, 5 mM DTT, 100 mM NaCl, 10 mM Tris-HCl pH 7.5, 0.02 % NaN3, 1.0 mM [U-10% 13C; U-100% 15N] HR2876C.006, 5 mM DTT, 100 mM NaCl, 10 mM Tris-HCl pH 7.5, 0.02 % NaN3	90% H2O/10% D2O		6.5	ambient	298
6	3D 1H-13C arom NOESY	1.0 mM [U-100% 13C; U-100% 15N] HR2876C.003, 5 mM DTT, 100 mM NaCl, 10 mM Tris-HCl pH 7.5, 0.02 % NaN3, 1.0 mM [U-10% 13C; U-100% 15N] HR2876C.006, 5 mM DTT, 100 mM NaCl, 10 mM Tris-HCl pH 7.5, 0.02 % NaN3, 1.0 mM [U-10% 13C; U-100% 15N] HR2876C.006, 5 mM DTT, 100 mM NaCl, 10 mM Tris-HCl pH 7.5, 0.02 % NaN3	90% H2O/10% D2O		6.5	ambient	298
7	3D simutaneous 13C-aromatic,13C-aliphatic,15N edited 1H-1H NOESY	1.0 mM [U-100% 13C; U-100% 15N] HR2876C.003, 5 mM DTT, 100 mM NaCl, 10 mM Tris-HCl pH 7.5, 0.02 % NaN3, 1.0 mM [U-10% 13C; U-100% 15N] HR2876C.006, 5 mM DTT, 100 mM NaCl, 10 mM Tris-HCl pH 7.5, 0.02 % NaN3, 1.0 mM [U-10% 13C; U-100% 15N] HR2876C.006, 5 mM DTT, 100 mM NaCl, 10 mM Tris-HCl pH 7.5, 0.02 % NaN3	90% H2O/10% D2O		6.5	ambient	298
8	2D 1H-15N HSQC	1.0 mM [U-100% 13C; U-100% 15N] HR2876C.003, 5 mM DTT, 100 mM NaCl, 10 mM Tris-HCl pH 7.5, 0.02 % NaN3, 1.0 mM [U-10% 13C; U-100% 15N] HR2876C.006, 5 mM DTT, 100 mM NaCl, 10 mM Tris-HCl pH 7.5, 0.02 % NaN3, 1.0 mM [U-10% 13C; U-100% 15N] HR2876C.006, 5 mM DTT, 100 mM NaCl, 10 mM Tris-HCl pH 7.5, 0.02 % NaN3	90% H2O/10% D2O		6.5	ambient	298
9	3D HCCH-TOCSY	1.0 mM [U-100% 13C; U-100% 15N] HR2876C.003, 5 mM DTT, 100 mM NaCl, 10 mM Tris-HCl pH 7.5, 0.02 % NaN3, 1.0 mM [U-10% 13C; U-100% 15N] HR2876C.006, 5 mM DTT, 100 mM NaCl, 10 mM Tris-HCl pH 7.5, 0.02 % NaN3, 1.0 mM [U-10% 13C; U-100% 15N] HR2876C.006, 5 mM DTT, 100 mM NaCl, 10 mM Tris-HCl pH 7.5, 0.02 % NaN3	90% H2O/10% D2O		6.5	ambient	298

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE	800
2	Varian	INOVA	600
3	Varian	INOVA	600

NMR Refinement
Method	Details	Software
distance geometry, simulated annealing, molecular dynamics, null	null, null	CNS

NMR Ensemble Information
Conformer Selection Criteria	target function
Conformers Calculated Total Number	100
Conformers Submitted Total Number	20
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	refinemen,structure solution,geometry optimization	CNS		Brunger, Adams, Clore, Gros, Nilges and Read
2	refinement,geometry optimization,structure solution	CYANA	3.0	Guntert, Mumenthaler and Wuthrich
3	data analysis,refinement	AutoStructure	2.1	Huang, Tejero, Powers and Montelione
4	data analysis,chemical shift assignment	AutoAssign	2.1	Zimmerman, Moseley, Kulikowski and Montelione
5	processing	NMRPipe		Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
6	data analysis,peak picking,chemical shift assignment	XEASY		Bartels et al.
7	collection	TopSpin		Bruker Biospin
8	collection	VnmrJ		Varian
9	data analysis	Sparky		Goddard
10	geometry optimization	TALOS+		Shen, Cornilescu, Delaglio and Bax
11	geometry optimization	REDCAT		Valafar, Prestegard
12	structure validation	PSVS		Bhattacharya, Montelione
13	refinement	CYANA
14	refinement	CNS
15	refinement	AutoStructure

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.